Biblio
Survival and functional outcomes of molecularly defined childhood posterior fossa ependymoma: Cure at a cost. Cancer. 2019.
Spinal Myxopapillary Ependymomas Demonstrate a Warburg Phenotype. Clin Cancer Res. 2015.
Reply to 'Assembling the brain trust: the multidisciplinary imperative in neuro-oncology'. Nat Rev Clin Oncol. 2019.
Postmortem Tissue Donation: Giving Families the Ability to Choose. J Clin Oncol. 2022:JCO2102839.
. Personalizing the treatment of pediatric medulloblastoma: Polo-like kinase PLK1 as a molecular target in high-risk children. Cancer Res. 2013.
p53 and Meduloblastoma. Cold Spring Harb Perspect Med. 2015.
. A multi-institutional retrospective pooled outcome analysis of molecularly annotated pediatric supratentorial fused ependymoma. Neurooncol Adv. 2023;5(1):vdad057.
Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas. Acta Neuropathol. 2018.
Molecular correlates of cerebellar mutism syndrome in medulloblastoma. Neuro Oncol. 2019.
Mini-symposium: The molecular biology of medulloblastoma metastasis. Brain Pathol. 2019.
. Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade Gliomas. Cancer Cell. 2020;37(4):569-583.e5.
Cross-species analysis of SHH medulloblastoma models reveals significant inhibitory effects of trametinib on tumor progression. Cell Death Discov. 2023;9(1):347.
. Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome. Neuro Oncol. 2023.
Clinical implications of medulloblastoma subgroups: incidence of CSF diversion surgery. J Neurosurg Pediatr. 2014:1-7.
. The Burden of Surviving Childhood Medulloblastoma: A Population-Based, Matched Cohort Study in Ontario, Canada. J Clin Oncol. 2023:JCO2202466.
.